CTOs on the Move

Zipher Medical Affairs

www.ziphermed.com

 
Zipher provides results-oriented, strategic Medical Affairs consulting and program management services for life sciences companies from development through the lifecycle of your product.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Farnsworth Group

Farnsworth Group is a Indianapolis, IN-based company in the Business Services sector.

Davis Development

Davis Development is a multi-family housing developer based in Atlanta, Georgia who develop, construct, and manage upscale apartment communities.

Leidos

Leidos is a science and technology solutions leader working to address some of the world`s toughest challenges in national security, health, and engineering. The Company`s 23,000 employees support vital missions for our government and the commercial sector, develop innovative solutions to drive better outcomes, and defend our Nation`s digital and physical infrastructure from `new world` threats. Leidos is headquartered in Reston, Va. and had approximately $6 billion in revenues for fiscal year 2013, on a pro forma basis, following the spin-off of the company`s technical, engineering and enterprise IT business on Sept. 27, 2013. Miner holds a B.S. in both Computer Science and Mathematics from the U.S. Air Force Academy. He served in the Air Force for 10 years, and served another 14 years in the Air Force Reserves where he retired as a Lieutenant Colonel. While on active duty, he earned an M.S. in Operations Research from the Air Force Institute of Technology. Miner is also a graduate of the University of Virginia Darden Business School "The Executive Program".

Futuredontics

Futuredontics specializes in new patient acquisition through dental practice marketing and pay-per-lead. Brands include 1-800-DENTIST & Dentistry.com.

The Michael J. Fox Foundation for Parkinson's Research

The Michael J. Fox Foundation for Parkinsons Research is dedicated to finding a cure for Parkinsons disease through funded research and ensuring the development of improved therapies for those living with Parkinsons today.